Cell Therapy Catapult appoints Eversheds as legal adviser
Eversheds has been appointed as legal adviser to the Cell Therapy Catapult, a UK centre of excellence in cell therapy, following a competitive pitch process.
The law firm’s appointment will cover all aspects of the Cell Therapy Catapult’s operations, including intellectual property and life sciences issues, procurement and state aid, HR, real estate and construction.
The Cell Therapy Catapult was established by the UK government’s Technology Strategy Board in 2012 to grow the UK cell therapy industry by removing the barriers to translation of promising therapies and technologies into new products.
News from Eversheds
News from The Lawyer
Briefings from Eversheds
The notion of ‘gross negligence’ is an important matter for customers and institutions alike and has been reviewed by the High Court and Supreme Court in deciding a recent case.
This report includes an analysis of the results of Eversheds survey on the Employment Tribunal process, which is based on 180 responses.
Analysis from The Lawyer
Could Slater & Gordon achieve its stated aim of becoming a top consumer brand by acquiring Pannone?
The Mid Staffordshire Inquiry’s call for a duty of candour will have far-reaching effects on the NHS and clinical negligence - if it is ever implemented